Teligent Cash on Hand 2010-2021 | TLGT

Teligent cash on hand from 2010 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Teligent Annual Cash on Hand
(Millions of US $)
2020 $6
2019 $16
2018 $13
2017 $27
2016 $66
2015 $87
2014 $159
2013 $2
2012 $3
2011 $3
2010 $5
2009 $1
Teligent Quarterly Cash on Hand
(Millions of US $)
2021-06-30 $23
2021-03-31 $28
2020-12-31 $6
2020-09-30 $10
2020-06-30 $6
2020-03-31 $11
2019-12-31 $16
2019-09-30 $7
2019-06-30 $4
2019-03-31 $7
2018-12-31 $13
2018-09-30 $15
2018-06-30 $14
2018-03-31 $13
2017-12-31 $27
2017-09-30 $38
2017-06-30 $50
2017-03-31 $59
2016-12-31 $66
2016-09-30 $75
2016-06-30 $81
2016-03-31 $87
2015-12-31 $87
2015-09-30 $146
2015-06-30 $150
2015-03-31 $157
2014-12-31 $159
2014-09-30 $23
2014-06-30 $2
2014-03-31 $2
2013-12-31 $2
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $3
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $3
2011-09-30 $3
2011-06-30 $3
2011-03-31 $5
2010-12-31 $5
2010-09-30 $0
2010-06-30 $0
2010-03-31 $1
2009-12-31 $1
2009-09-30 $2
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00